Clinical trial
Hypersensitivity to Phosphodiesterase 3 Inhibition in Post-Traumatic Headache: A Randomized Clinical Trial
NCT05595993 is registered in ClinicalTrials.gov with Danish Headache Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hypersensitivity to Phosphodiesterase 3 Inhibition in Post-Traumatic Headache: A Randomized Clinical Trial
- Lead sponsor
- Danish Headache Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 25, 2022
- Completion date
- December 31, 2023
- Enrollment
- 21 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.